MedicaidPrior AuthHigh impact
Preferred Drug List (PDL) Update July 25, 2017- Pharmacy Services MAB 01-17-32
Pennsylvania Medicaid (DHS)·PA · Pharmacy·Pharmacy
Effective date
Jul 25, 2017
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid updated their Preferred Drug List (PDL) effective July 25, 2017, adding new drug classes and changing preferred/non-preferred status for hundreds of medications. Nine preferred drugs now require clinical prior authorization, and one new drug class (Intra-articular Hyaluronates) was added to the PDL.
Action Required
Immediately: Update prior authorization workflows for 9 new preferred drugs requiring clinical PA: Dysport, Eligard, Entresto, Granix, Hyalgan, Hymovis, Trelstar, Vantas, and Zoladex. Review complete PDL update at www.papdl.com and update billing system drug databases with new preferred/non-preferred classifications. Train staff on new Intra-articular Hyaluronates drug class requirements. Claims may be denied without proper prior authorization.